Katherine E. Simon, Katharine Russell, Alejandra Mondino et al. “A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD⁺ precursor combination.” Scientific Reports 14:12399 (2024).
 
Ming You, Xiumei Fan, Liang Tao et al. “Sub-acute toxicity study of nicotinamide mononucleotide via oral administration in beagle dogs.” Toxicology Reports 8:40–52 (2021).
 
Déborah Cardoso, Inès Barthélémy, Stéphane Blot et al. “Replenishing NAD⁺ content reduces aspects of striated-muscle disease in a dog model of Duchenne muscular dystrophy.” Skeletal Muscle 13:20 (2023).
 
Zhaowei Bian, Ziyang Li, Hao Chang et al. “Resveratrol ameliorates chronic stress in kennel dogs and mice by regulating gut microbiome and metabolome related to tryptophan metabolism.” Antioxidants 14(2):195 (2025).
 
Rachel L. Poole, Emily R. Woodall, Philip K. Byers et al. “Pharmacokinetic analysis of an oral multicomponent joint dietary supplement (containing trans-resveratrol) in dogs.” Pharmaceutics 9(3):30 (2017).
 
Ainara Tvarijonaviciute, Pablo Escribano-Durán, Aránzazu Torre-Noguera et al. “Effects of Coenzyme Q10 supplementation on oxidative stress and clinical status in dogs with mitral valve [issues].” Antioxidants 11(8):1427 (2022).
 
Liselotte B. Christiansen, Malene K. Morsing, Maria J. Reimann et al. “Pharmacokinetics of repeated oral dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with myxomatous mitral valve [issues].” Antioxidants 9(9):827 (2020).
 
Katarzyna Zabielska-Koczywąs, Roman Lechowski, Joanna Łojkowska et al. “The use of liposomes and nanoparticles as drug delivery systems to improve [condition redacted] treatment in dogs and cats.” Molecules 22:2167 (2017).
 
Yaarit Shilo-Benjamini, Eran Lavy, Noam Yair et al. “Therapeutic efficacy and pharmacokinetics of liposomal-[active redacted] injection: a pilot clinical study in dogs with naturally-occurring osteoarthritis.” Frontiers in Veterinary Science 10:1224452 (2023).
 
Margaret L. Hauck, Steven M. LaRue, Paul W. Petros et al. “Phase I trial of doxorubicin-containing low-temperature-sensitive liposomes in spontaneous canine [condition redacted].” Clinical Cancer Research 12(13):4004–4010 (2006).